Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06298396
Other study ID # CLTD5853
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 27, 2024
Est. completion date April 2025

Study information

Verified date May 2024
Source Cochlear
Contact Niva Shrestha
Phone +61296116177
Email nshrestha@cochlear.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to investigate the effect of stimulation parameters and different electrode modes on speech perception in adult cochlear implant recipients.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date April 2025
Est. primary completion date April 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Implanted with the CI600 Series (CI612, CI632, CI622, CI624), CI500 Series (CI512, CI513, CI532, CI522) or Freedom Series (CI24RE(CA), CI24RE(ST), CI24RE(CS), CI422) - At least three months after activation of the cochlear implant. - Eighteen years or older at the time of consent. - User of 900Hz ACE (Advanced Combination Encoder) strategy MAP. - Score of 20% or more for CNC words presented at 60dBSPL with CI alone in the test ear. - Fluent speaker in English. - Willing and able to provide written informed consent. Exclusion Criteria: - One or more electrodes turned off in the MAP used regularly. - Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator. - Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling. - Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation. - Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Program using default MAP
Each MAP uses a specific combination of stimulation parameters and electrode mode.
Program using low-power 1 (LP1) MAP
Each MAP uses a specific combination of stimulation parameters and electrode mode.
Program using low-power 2 (LP2) MAP
Each MAP uses a specific combination of stimulation parameters and electrode mode.
Program using low-power 3 (LP3) MAP
Each MAP uses a specific combination of stimulation parameters and electrode mode.

Locations

Country Name City State
Australia Cochlear Macquarie Macquarie Park New South Wales

Sponsors (2)

Lead Sponsor Collaborator
Cochlear Avania

Country where clinical trial is conducted

Australia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Paired difference in percentage CNC words correct between default and LP1 MAPs in quiet setting Speech perception in quiet will be measured using recorded CNC monosyllabic words at 60 dB SPL from S0 position to emulate conversational levels. The goal of speech perception assessment in quiet is to compare % words correct for each of the conditions. week 4 and week 8
Primary Paired difference in dB SRT (AuSTIN) between default and LP1 MAPs in noise Speech perception in noise will be measured using the Australian Speech Test in Noise (AuSTIN), which is a test that uses recorded BKB-like target sentences. The goal of the speech perception test in noise is to provide the SNR for 50% speech intelligibility. week 4 and week 8
Secondary Paired difference in percentage CNC words correct between LP1 MAP and LP2 MAP in quiet setting Speech perception in quiet will be measured using recorded CNC monosyllabic words at 60 dB SPL from S0 position to emulate conversational levels. The goal of speech perception assessment in quiet is to compare % words correct for each of the conditions. week 4 and week 8
Secondary Paired difference in dB SRT (AuSTIN) between LP1 and LP2 MAPs in noise Speech perception in noise will be measured using the Australian Speech Test in Noise (AuSTIN), which is a test that uses recorded BKB-like target sentences. The goal of the speech perception test in noise is to provide the SNR for 50% speech intelligibility. week 4 and week 8
Secondary Paired difference in percentage CNC words correct between LP1 and LP3 MAPs in quiet setting Speech perception in quiet will be measured using recorded CNC monosyllabic words at 60 dB SPL from S0 position to emulate conversational levels. The goal of speech perception assessment in quiet is to compare % words correct for each of the conditions. week 4 and week 8
See also
  Status Clinical Trial Phase
Completed NCT04281953 - Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
Not yet recruiting NCT05973669 - MED-EL Remote Care Multi-Center Feasibility Study N/A
Completed NCT04601909 - FX-322 in Adults With Age-Related Sensorineural Hearing Loss Phase 1
Active, not recruiting NCT04479761 - Sensory Integration of Auditory and Visual Cues in Diverse Contexts N/A
Recruiting NCT05043207 - A Study Protocol for the Validation of UAud in a Clinical Setting. N/A
Recruiting NCT04066270 - Inventory of Radiological and Vestibular Function in Cochlear Implant Candidates
Recruiting NCT04070937 - Correlation of Radiological Lesions With Vestibular Function in Patients With Bilateral Vestibulopathy
Completed NCT03512951 - Subjective Evaluation of a Sound Processing Method for Hearing Aids on Auditory Distance Perception N/A
Completed NCT05855005 - Direct-to-Consumer Hearing Aids and Listening Effort N/A
Recruiting NCT05599165 - Speech Perception in Bimodal Hearing N/A
Completed NCT05101083 - Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids N/A
Completed NCT05521308 - Investigating Hearing Aid Frequency Response Curves N/A
Completed NCT05072457 - Benefit of Assistive Listening Device for Lateralization N/A
Recruiting NCT05776459 - Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) Phase 2
Completed NCT05086276 - FX-322 in Adults With Acquired Sensorineural Hearing Loss Phase 2
Recruiting NCT06058767 - Preschool Hearing Screening N/A
Completed NCT05180630 - Sound Quality Comparisons With Different Hearing Aid Couplings and Venting Systems N/A
Completed NCT03613909 - Acceptance of the CP950 Sound Processor N/A
Active, not recruiting NCT03352154 - Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants N/A
Completed NCT04629664 - FX-322 in Adults With Severe Sensorineural Hearing Loss Phase 1